HEIDI STERTZEL: Open Payments
NPI 1831606748 · POTTSVILLE, PA. Company-reported industry payments from CMS Open Payments. A payment does not imply wrongdoing.
See the full provider profile for registry, prescribing and billing details.
Industry payments (Sunshine Act)
Source: CMS Open Payments general payments. Payments from drug and device companies are reported by the companies; they do not imply wrongdoing and are separate from Medicare billing.
$1,310 in 60 payments from 14 companies in 2025. Trend: 2023 $861 · 2024 $1,870 · 2025 $1,310
Food & beverage: $1,226Education: $84
| Company | Payments | Amount |
|---|---|---|
| Janssen Biotech, Inc. | 14 | $340 |
| Takeda Pharmaceuticals U.S.A., Inc. | 9 | $168 |
| Regeneron Healthcare Solutions, Inc. | 6 | $160 |
| Salix Pharmaceuticals, a division of Bausch Health US, LLC | 6 | $113 |
| ABBVIE INC. | 5 | $109 |
| Phathom Pharmaceuticals, Inc. | 3 | $95 |
| Aimmune Therapeutics, Inc. | 5 | $81 |
| Madrigal Pharmaceuticals | 2 | $55 |
| Ardelyx, Inc. | 2 | $50 |
| PFIZER INC. | 3 | $44 |
Products named: TREMFYA, DUPIXENT, ENTYVIO, XIFAXAN, VOQUEZNA, ZENPEP, RINVOQ, REZDIFFRA.
Industry payments across PA — which companies pay providers there.
